Teva
Pharm prices $15 bln in
**tes to
fund Allergan generics deal
TEL AVIV, July 19 (Reuters) –
Teva Pharmaceutical Industries
Ltd said on Tuesday it successfully priced a debt
offering for $15 billion worth of senior
**tes to help
fund its
acquisition of Allergan…
